An Innovative Image-Based Method for Extensibility Assessment

April 22, 2025 updated by: Shaimaa Mohamed Ahmed Elsayeh, Cairo University

Revolutionizing Scar Evaluation: An Innovative Image-Based Method for Extensibility Assessment

This study uses a mixed-method design combining a quasi-experimental, single-group pre-post intervention with a methodological validation approach.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

  1. Quasi-experimental, single-group pre-post intervention:

    Participants will receive a standardized physical therapy protocol targeting scar contracture. After intervention, scar extensibility will be measured using traditional tools (Vancouver Scar Scale, tonometer) and a newly developed image-based method.

  2. Methodological validation approach: The image-based method will be tested for:

    • Reliability (test-retest, inter-rater)
    • Validity (concurrent validity against established tools and construct validity)

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New Cairo
      • Cairo, New Cairo, Egypt, 02
        • Shaimaa Mohamed Ahmed Elsayeh

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • History of clinically diagnosed scar contracture following thermal burns.
  • Presence of scars (≥6 months post-burn) to ensure stability for accurate assessment.
  • Scars located on functionally mobile areas (e.g., limbs) where extensibility impacts daily activities.
  • Willingness to undergo a standardized physical therapy intervention.
  • Ability to provide informed consent and comply with all study procedures.

Exclusion Criteria:

  • Active infection, unhealed wounds, or unstable scars at the assessment site.
  • Diagnosed systemic diseases affecting collagen synthesis or wound healing (e.g., scleroderma, uncontrolled diabetes).
  • History of experimental or non-standard scar treatment within the last 3 months.
  • Severe cognitive impairments or communication barriers that interfere with understanding or participation.
  • Pregnant or lactating women, due to hormonal influences on tissue healing and collagen metabolism.
  • Concurrent participation in other physical therapy or rehabilitation studies targeting scar management.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Traditional physical therapy group

This study uses a mixed-method design combining a quasi-experimental, single-group pre-post intervention with a methodological validation approach.

Participants will receive a standardized physical therapy protocol targeting scar contracture. After intervention, scar extensibility will be measured using traditional tools (Vancouver Scar Scale, tonometer) and a newly developed image-based method. The image-based method will be tested for:

  • Reliability (test-retest, inter-rater)
  • Validity (concurrent validity against established tools and construct validity)
Application of laser three times per week in addition to applying deep friction massage, stretching exercises along with the uses of pressure garment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Vancouver Scar Scale (VSS)
Time Frame: Baseline and three months after the intervention
to evaluate vascularity, pigmentation, pliability, and scar height.
Baseline and three months after the intervention
Firmness and pliability at the scar site
Time Frame: Baseline and three months after the intervention
Tonometry will be used to assess tissue firmness and pliability at the scar site.
Baseline and three months after the intervention
Proposed Image-Based Method
Time Frame: Baseline and three months after the intervention

the scar images before and after the intervention will go through three steps:

  • Image Acquisition: High-resolution digital images of scars will be captured using a standardized protocol (fixed camera settings, lighting, distance).
  • Image Preprocessing: Images will be converted to grayscale, and regions of interest (ROI) manually or automatically defined.
  • Image Analysis: The standard deviation (STD) of pixel intensities within the ROI will be calculated as an indicator of tissue extensibility and collagen fiber cross-linking patterns will be detected and quantified using advanced image processing algorithms.
Baseline and three months after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Shaimaa MA Elsayeh, PhD, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 15, 2024

Primary Completion (Estimated)

May 4, 2025

Study Completion (Estimated)

May 12, 2025

Study Registration Dates

First Submitted

April 16, 2025

First Submitted That Met QC Criteria

April 22, 2025

First Posted (Actual)

April 23, 2025

Study Record Updates

Last Update Posted (Actual)

April 23, 2025

Last Update Submitted That Met QC Criteria

April 22, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • P.T.REC/012/005678

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe